Victory Capital Management Inc. Sells 342,273 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Victory Capital Management Inc. decreased its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 16.5% in the fourth quarter, HoldingsChannel reports. The fund owned 1,735,053 shares of the real estate investment trust’s stock after selling 342,273 shares during the quarter. Victory Capital Management Inc.’s holdings in Sabra Health Care REIT were worth $24,759,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. SG Americas Securities LLC lifted its stake in Sabra Health Care REIT by 30.3% in the 3rd quarter. SG Americas Securities LLC now owns 30,920 shares of the real estate investment trust’s stock worth $431,000 after purchasing an additional 7,184 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Sabra Health Care REIT by 7.6% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 85,427 shares of the real estate investment trust’s stock worth $1,191,000 after buying an additional 6,032 shares in the last quarter. Advisor Partners II LLC increased its stake in Sabra Health Care REIT by 163.8% during the third quarter. Advisor Partners II LLC now owns 119,344 shares of the real estate investment trust’s stock worth $1,664,000 after acquiring an additional 74,109 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd increased its position in shares of Sabra Health Care REIT by 15.0% during the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 37,565 shares of the real estate investment trust’s stock valued at $524,000 after purchasing an additional 4,886 shares during the last quarter. Finally, LDR Capital Management LLC purchased a new stake in shares of Sabra Health Care REIT in the third quarter valued at $7,076,000. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

SBRA has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft assumed coverage on Sabra Health Care REIT in a research note on Tuesday, January 30th. They set a “buy” rating and a $21.00 price target for the company. Wedbush reaffirmed an “outperform” rating and issued a $17.00 price target on shares of Sabra Health Care REIT in a research report on Thursday, February 29th. Five equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $15.77.

Sabra Health Care REIT Price Performance

NASDAQ:SBRA opened at $14.87 on Thursday. The firm’s fifty day moving average is $14.13 and its two-hundred day moving average is $14.04. The firm has a market cap of $3.44 billion, a price-to-earnings ratio of 297.40, a PEG ratio of 5.15 and a beta of 1.17. Sabra Health Care REIT, Inc. has a one year low of $10.30 and a one year high of $14.92. The company has a debt-to-equity ratio of 0.86, a quick ratio of 3.41 and a current ratio of 3.41.

Sabra Health Care REIT Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.